These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23789951)

  • 1. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
    Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
    Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier.
    Pinzón-Daza ML; Campia I; Kopecka J; Garzón R; Ghigo D; Riganti C
    Curr Drug Metab; 2013 Jul; 14(6):625-40. PubMed ID: 23869808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.
    Chaves C; Remiao F; Cisternino S; Decleves X
    Curr Neuropharmacol; 2017 Nov; 15(8):1156-1173. PubMed ID: 28474563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
    Löscher W; Potschka H
    NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.
    Tournier N; Declèves X; Saubaméa B; Scherrmann JM; Cisternino S
    Curr Pharm Des; 2011; 17(26):2829-42. PubMed ID: 21827411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
    Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
    Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.
    Bagal S; Bungay P
    Drug Discov Today Technol; 2014 Jun; 12():e79-85. PubMed ID: 25027378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC transporters and the blood-brain barrier.
    Begley DJ
    Curr Pharm Des; 2004; 10(12):1295-312. PubMed ID: 15134482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.
    Wanek T; Mairinger S; Langer O
    J Labelled Comp Radiopharm; 2013; 56(3-4):68-77. PubMed ID: 24285312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.
    Gil-Martins E; Barbosa DJ; Silva V; Remião F; Silva R
    Pharmacol Ther; 2020 Sep; 213():107554. PubMed ID: 32320731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CNS transporters for treatment of neurodegenerative diseases.
    Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
    Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting transporters for CNS drug delivery.
    Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
    [No Abstract]   [Full Text] [Related]  

  • 16. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
    Abdullahi W; Davis TP; Ronaldson PT
    AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
    Miller DS
    Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ABC of the blood-brain barrier - regulation of drug efflux pumps.
    Mahringer A; Ott M; Reimold I; Reichel V; Fricker G
    Curr Pharm Des; 2011; 17(26):2762-70. PubMed ID: 21827407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.
    Ronaldson PT; Persidsky Y; Bendayan R
    Glia; 2008 Dec; 56(16):1711-35. PubMed ID: 18649402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.